Association of a BACE1 Gene Polymorphism with Parkinson’s Disease in a Norwegian Population

Background. Parkinson’s disease (PD) and Alzheimer’s disease (AD) share pathological features, including amyloid-beta pathology. Amyloid-beta peptide is generated by sequential proteolysis of amyloid precursor protein (APP), and genetic variations in the processing pathway genes have been found to i...

Full description

Saved in:
Bibliographic Details
Main Authors: Johannes Lange, Kristin Aaser Lunde, Camilla Sletten, Simon Geir Møller, Ole-Bjørn Tysnes, Guido Alves, Jan Petter Larsen, Jodi Maple-Grødem
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Parkinson's Disease
Online Access:http://dx.doi.org/10.1155/2015/973298
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563713274544128
author Johannes Lange
Kristin Aaser Lunde
Camilla Sletten
Simon Geir Møller
Ole-Bjørn Tysnes
Guido Alves
Jan Petter Larsen
Jodi Maple-Grødem
author_facet Johannes Lange
Kristin Aaser Lunde
Camilla Sletten
Simon Geir Møller
Ole-Bjørn Tysnes
Guido Alves
Jan Petter Larsen
Jodi Maple-Grødem
author_sort Johannes Lange
collection DOAJ
description Background. Parkinson’s disease (PD) and Alzheimer’s disease (AD) share pathological features, including amyloid-beta pathology. Amyloid-beta peptide is generated by sequential proteolysis of amyloid precursor protein (APP), and genetic variations in the processing pathway genes have been found to increase the risk of AD; however, the contribution in PD is unknown. Methods. The aim of this study was to investigate whether candidate polymorphisms in five genes (ADAM10, BACE1, BACE2, PSEN2, and CLU) involved in the APP processing pathway affect PD risk in a population-based cohort of patients with incident PD and control subjects from the Norwegian ParkWest study. Results. We found an association of rs638405 in BACE1 with increased risk of PD, thus providing a novel link, at the genetic level, between amyloid-beta pathology and PD.
format Article
id doaj-art-7b9864cf9dd84e68b540b481b65b56e5
institution Kabale University
issn 2090-8083
2042-0080
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Parkinson's Disease
spelling doaj-art-7b9864cf9dd84e68b540b481b65b56e52025-02-03T01:12:44ZengWileyParkinson's Disease2090-80832042-00802015-01-01201510.1155/2015/973298973298Association of a BACE1 Gene Polymorphism with Parkinson’s Disease in a Norwegian PopulationJohannes Lange0Kristin Aaser Lunde1Camilla Sletten2Simon Geir Møller3Ole-Bjørn Tysnes4Guido Alves5Jan Petter Larsen6Jodi Maple-Grødem7The Norwegian Centre for Movement Disorders, Stavanger University Hospital, 4011 Stavanger, NorwayThe Norwegian Centre for Movement Disorders, Stavanger University Hospital, 4011 Stavanger, NorwayCentre for Organelle Research, University of Stavanger, 4036 Stavanger, NorwayDepartment of Biological Sciences, St. John’s University, New York, NY 11439, USADepartment of Neurology, Haukeland University Hospital, 5021 Bergen, NorwayThe Norwegian Centre for Movement Disorders, Stavanger University Hospital, 4011 Stavanger, NorwayThe Norwegian Centre for Movement Disorders, Stavanger University Hospital, 4011 Stavanger, NorwayThe Norwegian Centre for Movement Disorders, Stavanger University Hospital, 4011 Stavanger, NorwayBackground. Parkinson’s disease (PD) and Alzheimer’s disease (AD) share pathological features, including amyloid-beta pathology. Amyloid-beta peptide is generated by sequential proteolysis of amyloid precursor protein (APP), and genetic variations in the processing pathway genes have been found to increase the risk of AD; however, the contribution in PD is unknown. Methods. The aim of this study was to investigate whether candidate polymorphisms in five genes (ADAM10, BACE1, BACE2, PSEN2, and CLU) involved in the APP processing pathway affect PD risk in a population-based cohort of patients with incident PD and control subjects from the Norwegian ParkWest study. Results. We found an association of rs638405 in BACE1 with increased risk of PD, thus providing a novel link, at the genetic level, between amyloid-beta pathology and PD.http://dx.doi.org/10.1155/2015/973298
spellingShingle Johannes Lange
Kristin Aaser Lunde
Camilla Sletten
Simon Geir Møller
Ole-Bjørn Tysnes
Guido Alves
Jan Petter Larsen
Jodi Maple-Grødem
Association of a BACE1 Gene Polymorphism with Parkinson’s Disease in a Norwegian Population
Parkinson's Disease
title Association of a BACE1 Gene Polymorphism with Parkinson’s Disease in a Norwegian Population
title_full Association of a BACE1 Gene Polymorphism with Parkinson’s Disease in a Norwegian Population
title_fullStr Association of a BACE1 Gene Polymorphism with Parkinson’s Disease in a Norwegian Population
title_full_unstemmed Association of a BACE1 Gene Polymorphism with Parkinson’s Disease in a Norwegian Population
title_short Association of a BACE1 Gene Polymorphism with Parkinson’s Disease in a Norwegian Population
title_sort association of a bace1 gene polymorphism with parkinson s disease in a norwegian population
url http://dx.doi.org/10.1155/2015/973298
work_keys_str_mv AT johanneslange associationofabace1genepolymorphismwithparkinsonsdiseaseinanorwegianpopulation
AT kristinaaserlunde associationofabace1genepolymorphismwithparkinsonsdiseaseinanorwegianpopulation
AT camillasletten associationofabace1genepolymorphismwithparkinsonsdiseaseinanorwegianpopulation
AT simongeirmøller associationofabace1genepolymorphismwithparkinsonsdiseaseinanorwegianpopulation
AT olebjørntysnes associationofabace1genepolymorphismwithparkinsonsdiseaseinanorwegianpopulation
AT guidoalves associationofabace1genepolymorphismwithparkinsonsdiseaseinanorwegianpopulation
AT janpetterlarsen associationofabace1genepolymorphismwithparkinsonsdiseaseinanorwegianpopulation
AT jodimaplegrødem associationofabace1genepolymorphismwithparkinsonsdiseaseinanorwegianpopulation